Elimination of Intestinal Hypoxia in Complex Treatment of Intestinal Failure (Case Report)

Abstract

INTRODUCTION: Currently, various approaches to the treatment of intestinal failure (IF) are considered. In search for pathogenetically justified therapy, it is possible to use oxygenated saline enteral solution (OSES).

АIM: To demonstrate, by gas analysis of the introduced oxygenated saline enteral solution and the excreted intestinal fluid, the possibility of gas exchange in the intestine with increased oxygen extraction under hypoxic conditions.

An 8-year-old child with burdened premorbid history and severe community–acquired bilateral pleuropneumonia kept on mechanical ventilation, had signs of IF (disorder in passage, absence of independent defecation for more than two days). During treatment and observation of the child, enteral feeding was attempted with pharmacological stimulation with prokinetics, and introduction of laxative sorbent with prebiotic effect (lactulose). Because of non-effectiveness of these measures, it was decided to perform intestinal lavage with OSES introduced through the nasogastral tube. In 30 minites after start of OSES introduction, the gastrointestinal tract motility notably enhanced, in 1.5 hour from the beginning of the procedure, fractional passage of a significant amount of thick fecal masses was noted, after which intestinate — liquid stool stained yellow with bile, was obtained. During the procedure, a comparative analysis of the gas composition of the introduced OSES and excreted intestinate was done. In the excreted solution, 97-fold decrease of рО₂ from 659 to 6.8 mm Hg, and 3.6-fold increase in CO₂ tension from 23 to 85.7 mm Hg, were noted.

CONCLUSION: Oxygenation of the enteral environment by barbotage of a saline enteral solution introduced through a tube is an effective component of intensive therapy for intestinal failure syndrome, taking into account the ability of the gastrointestinal tract tissues to actively participate in gas exchange: extract oxygen and release carbon dioxide.

Keywords

intestinal hypoxia / intestinal failure / intestine / intensive therapy

References

[1] Lilja HE, Wefer H, Nyström N, et al. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome. Microbiome. 2015;(3):18. doi: 10.1186/s40168-015-0084-7

[2] Lilja H.E., Wefer H., Nyström N., et al. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome // Microbiome. 2015. Vol. 3. P. 18. doi: 10.1186/s40168-015-0084-7

[3] Pironi L, Sasdelli AS. Management of the patient with chronic intestinal pseudo-obstruction and intestinal failure. Gastroenterol Clin North Am. 2019;48(4):513–24. doi: 10.1016/j.gtc.2019.08.005

[4] Pironi L., Sasdelli A.S. Management of the Patient with Chronic Intestinal Pseudo-Obstruction and Intestinal Failure // Gastroenterol. Clin. North Am. 2019. Vol. 48, No. 4. С. 513–524. doi: 10.1016/j.gtc.2019.08.005

[5] Ashurova OYu, Kodirova GR. Primeneniye enteral’noy oksigenoterapii (kislorodnogo kokteylya) v kompleksnom vosstanovitel’nom lechenii gipoksii i khronicheskikh bolezney organov dykhaniya. Internauka. 2020;(46):36–7. Available at: https://www.internauka.org/journal/science/internauka/175. Accessed: 2023 April 04. (In Russ).

[6] Ашурова О.Ю., Кодирова Г.Р. Применение энтеральной оксигенотерапии (кислородного коктейля) в комплексном восстановительном лечении гипоксии и хронических болезней органов дыхания // Интернаука. 2020. № 46 (175). С. 36–37. Доступно по: https://www.internauka.org/journal/science/internauka/175. Ссылка активна на 04.04.2023.

[7] Della Rocca Y, Fonticoli L, Rajan TS, et al. Hypoxia: molecular pathophysiological mechanisms in human diseases. J Physiol Biochem. 2022;78(4):739–52. doi: 10.1007/s13105-022-00912-6

[8] Della Rocca Y., Fonticoli L., Rajan T.S., et al. Hypoxia: molecular pathophysiological mechanisms in human diseases // J. Physiol. Biochem. 2022. Vol. 78, No. 4. С. 739–752. doi: 10.1007/s13105-022-00912-6

[9] Vorvul AO, Bobyntsev II, Medvedeva OA. On mechanisms of increased intestinal wall permeability under stress. Humans and Their Health. 2022;25(2):43–63. (In Russ). doi: 10.21626/vestnik/2022-2/05

[10] Ворвуль А.О., Бобынцев И.И., Медведева О.А. К вопросу о механизмах повышения проницаемости стенки кишечника при стрессе // Человек и его здоровье. 2022. Т. 25, № 2. С. 43–63. doi: 10.21626/vestnik/2022-2/05

[11] Bykov MV, Lazarev VV, Shchienko VI, et al. An experience of using bowel lavage in acute infectious diseases in children at resuscitation and intensive care units. Infectious Diseases. 2016;14(2):41–6. (In Russ). doi: 10.20953/1729-9225-2016-2-41-46

[12] Быков М.В., Лазарев В.В., Щиенко В.И., и др. Опыт применения кишечного лаважа при острых инфекционных заболеваниях у детей в отделении реанимации и интенсивной терапии // Инфекционные болезни. 2016. Т. 14, № 2. С. 41–46. doi: 10.20953/ 1729-9225-2016-2-41-46

[13] Slivin OA, Tarnovskaya DS, Mazurok VA, et al. Intestinal Oxygenation in the Intensive Therapy in Pregnant Woman with Flu A (H1N1). Clinical Case. Annals of Critical Care. 2017;(3):69–75. (In Russ). doi: 10.21320/1818-474X-2017-3-69-75

[14] Сливин О.А., Тарновская Д.С., Мазурок В.А., и др. Интестинальная оксигенация в составе интенсивной терапии у беременной с гриппом А(H1N1). Клиническая демонстрация // Вестник интенсивной терапии. 2017. № 3. С. 69–75. doi: 10.21320/1818-474X-2017-3-69-75

[15] Henry W. III. Experiments on the Quantity of Gases Absorbed by Water, at Different Temperatures, and under Different Pressures. Phil Trans R Soc. 1803;93:29–274. doi: 10.1098/rstl.1803.0004

[16] Henry W. III. Experiments on the quantity of gases absorbed by water, at different temperatures, and under different pressures // Phil. Trans. R. Soc. 1803. Vol. 93. С. 29–274. doi: 10.1098/rstl.1803.0004

[17] Eiro N, Fraile M, González–Jubete A, et al. Mesenchymal (stem) stromal cells based as new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and challenges. Int J Mol Sci. 2022;23(16):8905. doi: 10.3390/ijms23168905

[18] Eiro N., Fraile M., González–Jubete A., et al. Mesenchymal (stem) stromal cells based as new therapeutic alternative in inflammatory bowel disease: basic mechanisms, experimental and clinical evidence, and challenges // Int. J. Mol. Sci. 2022. Vol. 23, No. 16. С. 8905. doi: 10.3390/ijms23168905

[19] Bykov MV, Prometneu DV, Mayorov AD, et al. Oxygenated salt enteral solution in the treatment of a child with pancreonekrosis. Russian Journal of Pediatric Surgery, Anesthesia and Intensive Care. 2020;10(2):209–16. (In Russ). doi: 10.17816/psaic673

[20] Быков М.В., Прометной Д.В., Майоров А.Д., и др. Оксигениро-ванный солевой энтеральный раствор в лечении ребенка с панкреонекрозом // Российский вестник детской хирургии, анестезиологии и реаниматологии. 2020. Т. 10, № 2. С. 209–216. doi: 10.17816/psaic673

[21] Berlin P, Barrantes I, Reiner J, et al. Dysbiosis and reduced small intestinal function are required to induce intestinal insufficiency in mice. Am J Physiol Gastrointest Liver Physiol. 2023;324(1):10–23. doi: 10.1152/ajpgi.00201.2022

[22] Berlin P., Barrantes I., Reiner J., et al. Dysbiosis and reduced small intestinal function are required to induce intestinal insufficiency in mice // Am. J. Physiol. Gastrointest. Liver Physiol. 2023. Vol. 324, No. 1. С. G10–G23. doi: 10.1152/ajpgi.00201.2022

[23] Mazurok VA, Antonova IV, Golovkin AS, et al. Gut insufficiency in critical illness: clinico-morphological forms, ways of correction. Translational Medicine. 2016;3(5):42–52. (In Russ).

[24] Мазурок В.А., Антонова И.В., Головкин А.С., и др. Энтеропатии критических состояний: клинико-морфологические образы, возможности коррекции // Трансляционная медицина. 2016. Т. 3, № 5. С. 42–52.

[25] Choi W, Yeruva S, Turner JR. Contributions of intestinal epithelial barriers to health and disease. Exp Cell Res. 2017;358(1):71–7. doi: 10.1016/j.yexcr.2017.03.036

[26] Choi W., Yeruva S., Turner J.R. Contributions of intestinal epithelial barriers to health and disease // Exp. Cell Res. 2017. Vol. 358, No. 1. С. 71–77. doi: 10.1016/j.yexcr.2017.03.036

[27] Mazurok VA, Belikov VL, Slivin OA, et al. Improving of systemic oxygenation by enteral oxygen therapy. Russian Journal of Anesthesiology and Reanimatology. 2014;(5):21–6. (In Russ).

[28] Мазурок В.А., Беликов В.Л., Сливин О.А., и др. Возможности повышения системной оксигенации посредством энтеральной оксигенотерапии // Анестезиология и реаниматология. 2014. № 5. С. 21–26.

[29] Bykov MV, Chernyshev DV, Loptev YuA, et al. The use of oxygenated saline enteral solution in the complex intensive care of severe community-acquired pneumonia caused by COVID-19. Lechashchiy Vrach. 2020;(7):58–63. (In Russ). doi: 10.26295/OS.2020.71.86.003

[30] Быков М.В., Чернышёв Д.В., Лоптев Ю.А., и др. Использование оксигенированного солевого энтерального раствора в составе комплексной интенсивной терапии тяжелых внебольничных пневмоний, вызванных CO // Лечащий врач. 2020. № 7. С. 58–63. doi: 10.26295/OS.2020.71.86.003

[31] Coxon RV. The effect of intragastric oxygen on the oxygenation of arterial and portal blood in hypoxic animals. Lancet. 1960; 1(7138):1315–7. doi: 10.1016/s0140-6736(60)92302-3

[32] Coxon R.V. The effect of intragastric oxygen on the oxygenation of arterial and portal blood in hypoxic animals // Lancet. 1960. Vol. 1, No. 7138. С. 1315–1317. doi: 10.1016/s0140-6736(60)92302-3

[33] Matkevich VA, Luzhnikov EA, Belova MV, et al. The role of intestinal translocation in the origin of endotoxemia in acute poisoning and detoxification effect of intestinal lavage. Zhurnal imeni N.V. Sklifosovskogo ‘Neotlozhnaya Meditsinskaya Pomoshch’. 2015; (4):16–21. (In Russ).

[34] Маткевич В.А., Лужников Е.А., Белова М.В., и др. Роль кишечной транслокации в генезе эндотоксемии при острых отравлениях и детоксикационный эффект кишечного лаважа // Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2015. № 4. С. 16–21.

[35] Kalinin RE, Suchkov IA, Raitsev SN, et al. Role of Hypoxia-Inducible Factor 1α in Adaptation to Hypoxia in the Pathogenesis of Novel Coronavirus Disease 2019. I. P. Pavlov Russian Medical Biological Herald. 2024;32(1):133–44. (In Russ). doi: 10.17816/PAVLOVJ165536

[36] Калинин Р.Е., Сучков И.А., Райцев С.Н., и др. Роль фактора, индуцируемого гипоксией, 1α при адаптации к гипоксии в патогенезе новой коронавирусной болезни 2019 // Российский медико-биологический вестник имени академика И. П. Павлова. 2024. Т. 32, № 1. C. 133–144. doi: 10.17816/PAVLOVJ165536

[37] Borodulina EA, Yakovleva EV, Borodulina EV. Characteristics of patients with disseminated lung diseases in the intensive therapy unit. Nauka Molodykh (Eruditio Juvenium). 2018;6(2):252–8. (In Russ). doi: 10.23888/HMJ201862252-258

[38] Бородулина Е.А., Яковлева Е.В., Бородулина Э.В. Характеристика пациентов с диссеминированными заболеваниями легких в отделении реанимации и интенсивной терапии // Наука молодых (Eruditio Juvenium). 2018. Т. 6, № 2. С. 252–258. doi: 10.23888/HMJ201862252-258

RIGHTS & PERMISSIONS

Eco-Vector